Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo-Controlled Proof of Concept Study to Investigate ANB020 Activity in Adult Patients With Severe Eosinophilic Asthma

NCT03469934 is registered in ClinicalTrials.gov with AnaptysBio, Inc. as lead sponsor.

NCT NCT03469934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03469934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo-Controlled Proof of Concept Study to Investigate ANB020 Activity in Adult Patients With Severe Eosinophilic Asthma
Lead sponsor
AnaptysBio, Inc.
Phase
Phase 2
Overall status
Completed
Start date
November 14, 2017
Completion date
October 30, 2018
Enrollment
25 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

eosinophilic asthma